IMPACT THERAP-B 07630·

Gross margin 100.00%--95.36%4.64%95.89%0.53% Net margin -8.48%---759.40%750.92%-773.64%14.24% ROE -3.85%--34.23%38.08%30.89%3.33% ROA -6.44%---65.51%59.07%-88.46%22.95% Revenue growth -----85.74%--14.02%99.76% Attributable profit growth -----7034.00%---16.16%7017.84% Debt-to-assets 130.80%--291.39%160.59%386.35%94.96% Current ratio 0.81--4.183.373.081.10 Operating cash flow / net profit -0.85--0.321.170.320.00 Operating cash flow / revenue 7.19%---242.38%249.57%-250.66%8.28%

Gross margin 97.67%--90.77%6.90% Net margin -510.10%---86.33%423.78% Revenue growth ----316.83%-- Attributable profit growth ----29.46%-- Debt-to-assets ----32.82%-- Current ratio ----8.06-- Operating cash flow / net profit -0.23---0.270.03 Operating cash flow / revenue 119.55%--23.17%96.38%

Revenue 235.22M--33.55M85.74%38.25M14.02% Other income and gains 11.36M--12.36M8.80%8.29M32.97% Gross profit 235.22M--31.99M86.40%36.68M14.65% Selling and distribution expenses ----2.50M--13.84M453.02% Administrative expenses 48.11M--42.43M11.81%69.14M62.94% Net finance costs 571.00K--55.56M9629.95%68.66M23.59% Income tax ----3.00K--1.00K66.67% Operating profit -19.37M---199.19M928.52%-227.26M14.09% Profit before tax -19.94M---254.75M1177.72%-295.92M16.16% Net profit -19.94M---254.75M1177.74%-295.92M16.16% Net profit attributable to owners 3.67M---254.75M7034.00%-295.92M16.16%

Revenue 25.24M--105.19M316.83% Other income and gains 4.21M--29.43M599.00% Cost of sales 588.00K--9.71M1552.04% Gross profit 24.65M--95.48M287.36% Selling and distribution expenses 5.23M--22.84M337.14% Administrative expenses 29.24M--50.30M72.00% Net finance costs 34.05M--24.83M27.09% Income tax 0--0-- Profit before tax -128.73M---90.81M29.46% Net profit -128.73M---90.81M29.46% Net profit attributable to owners -128.73M---90.81M29.46%

Cash and cash equivalents 271.32M--230.12M15.18%258.53M12.35% Trade and bills receivables --------7.44M-- Inventories ----4.35M--26.98M520.04% Total current assets 301.95M--374.39M23.99%322.98M13.73% Total assets 309.70M--388.89M25.57%334.52M13.98% Total current liabilities 373.72M--89.53M76.04%104.79M17.05% Total liabilities 405.09M--1.13B179.73%1.29B14.05% Equity attributable to owners -95.39M---744.29M680.26%-957.89M28.70% Total equity -95.39M---744.29M680.26%-957.89M28.70%

Cash and cash equivalents ----820.55M-- Trade and bills receivables ----38.03M-- Inventories ----24.88M-- Total current assets ----1.14B-- Total assets ----1.15B-- Total current liabilities ----141.95M-- Total liabilities ----379.01M-- Equity attributable to owners ----775.77M-- Total equity ----775.77M--

Net cash from operating activities 16.90M---81.31M581.04%-95.88M17.92% Net cash from investing activities 125.01M---109.85M187.88%112.82M202.70% Net cash from financing activities 39.55M--148.33M275.07%13.47M90.92% Net change in cash 181.46M---42.83M123.60%30.41M170.98%

Net cash from operating activities 30.17M--24.38M19.21% Net cash from investing activities -68.82M---249.12M261.98% Net cash from financing activities 19.01M--796.33M4088.14% Net change in cash -19.64M--571.59M3010.79%